Article
Research record from Clin Microbiol Infect, 2026-03-27. PMID 41905558.
Article
Research record from Infect Dis Ther, 2026-04-04. PMID 41934527.
Article
Research record from Diagnostics (Basel), 2026-04-20. PMID 42072850.
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgA antibodies against SARS-CoV-2 using the S1 domain of the spike protein.
For professionals
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein, including the receptor binding domain (RBD).
For professionals
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgG antibodies against SARS-CoV-2 using a modified nucleocapsid protein (NCP) containing only diagnostically relevant epitopes.
For professionals
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgM antibodies against SARS-CoV-2 using a modified nucleocapsid protein (NCP) containing only diagnostically relevant epitopes.
For professionals
Tests
A proprietary enzyme-linked immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein, including the receptor binding domain (RBD).
For professionals
Glossary Term
Validation evidence that an assay detects the range of variants, genotypes, or serotypes it claims to cover. For evolving targets such as influenza or SARS-CoV-2, inclusivity statements carry a validation date and should be checked against circulating variant lists at procurement time.
Performance Metrics
Indicators
Molecular detection and typing of influenza A and B viruses.
Article
Research record from J Clin Med, 2026-09-11. PMID 42795842.
Tests
A proprietary serology assay that can be used to measure IgG antibodies against the SARS-CoV-2 nucleocapsid protein (N).
For professionals